Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022214826 - BACTERIOPHAGE COMPOSITIONS FOR TREATING CLOSTRIDIUM PERFRINGENS INFECTIONS

Publication Number WO/2022/214826
Publication Date 13.10.2022
International Application No. PCT/GB2022/050887
International Filing Date 08.04.2022
IPC
A61K 35/76 2015.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
76Viruses; Subviral particles; Bacteriophages
A61P 31/04 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
C12N 7/00 2006.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
7Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
CPC
A61K 35/76
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
76Viruses; Subviral particles; Bacteriophages
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
C12N 2795/10121
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2795Bacteriophages
00011Bacteriophages
10011dsDNA Bacteriophages
10111Myoviridae
10121Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N 2795/10132
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2795Bacteriophages
00011Bacteriophages
10011dsDNA Bacteriophages
10111Myoviridae
10132Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N 2795/10221
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2795Bacteriophages
00011Bacteriophages
10011dsDNA Bacteriophages
10211Podoviridae
10221Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N 2795/10232
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2795Bacteriophages
00011Bacteriophages
10011dsDNA Bacteriophages
10211Podoviridae
10232Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Applicants
  • APARON LTD. [GB]/[GB]
Inventors
  • BROWN, Joseph Charles Samuel
  • EDWARDS, Joseph Riziero
  • KAY, Sammy James
  • DENNESS, Ellen Olivia
  • STANFORD, Christopher Jeremy
Agents
  • DEHNS
Priority Data
63/173,04109.04.2021US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) BACTERIOPHAGE COMPOSITIONS FOR TREATING CLOSTRIDIUM PERFRINGENS INFECTIONS
(FR) COMPOSITIONS DE BACTÉRIOPHAGES DESTINÉES AU TRAITEMENT D'INFECTIONS PAR CLOSTRIDIUM PERFRINGENS
Abstract
(EN) The invention relates to the field of phage therapy. It particularly relates to providing phages, phage-based compositions and methods for treating or preventing bacterial infections, particularly C. perfringens, in animals, including humans, aquaculture and livestock. The invention also relates to uses of the compositions as a feedstuff and as a biological decontaminator in feed and food products for human and animal consumption.
(FR) L'invention se rapporte au domaine de la thérapie génique. L'invention se rapporte en particulier à des phages, à des compositions à base de phages et à des méthodes destinées à traiter ou à prévenir des infections bactériennes, en particulier à C. perfringens, chez des animaux, y compris les humains, l'aquaculture et le bétail. L'invention se rapporte également à des utilisations des compositions en tant qu'aliment et en tant que décontaminateur biologique dans des aliments et des produits alimentaires destinés à la consommation humaine et animale.
Latest bibliographic data on file with the International Bureau